Evidence map›Paper›PMID 25093240›Full record

ArticleACS nano2014

Guiding brain tumor resection using surface-enhanced Raman scattering nanoparticles and a hand-held Raman scanner.

Hazem Karabeber, Ruimin Huang, Pasquale Iacono, Jason M Samii, Ken Pitter, Eric C Holland, Moritz F Kircher

Abstract readValidation Study
In one paragraph

Article in ACS nano, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Design and Synthesis of SERS Materials for In Vivo Molecular Imaging and Biosensing.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  17. Review
  18. Review
  19. Review
  20. Multiplexed imaging in oncology.Nature biomedical engineering · 2022
    Review

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hazem KarabeberDepartment of Radiology, Memorial Sloan Kettering Cancer Center , New York, New York 10065, United States.
Ruimin Huang
Pasquale Iacono
Jason M Samii
Ken Pitter
Eric C Holland
Moritz F Kircher

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
Molecular Imaging: Training for OncologyR25CA096945 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI HRICAK, HEDVIG · 2002 to 2013
$5.2M
MRI-Photoacoustic-Raman Nanostars for Pre- and Intraoperative Multimodal ImagingR01EB017748 · NIBIB · SLOAN-KETTERING INST CAN RESEARCH · PI KIRCHER, MORITZ FLORIAN · 2014 to 2017
$1.6M
Interactions of Stress and NicotineK08DA016396 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BERMAN, JOSHUA A · 2005 to 2009
$866k
Combined Pre & Intraoperative Brain Tumor Imaging Strategy using a Dual-ModalityK08CA163961 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI KIRCHER, MORITZ FLORIAN · 2012 to 2016
$845k
Characterizing the functional stem-like properties of primary and recurrent gliomF31NS076028 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI PITTER, KENNETH L · 2011 to 2013
$141k
NCI NIH HHS 2R25-CA096945NCI NIH HHS K08 CA163961NCI NIH HHS NIH K08 CA16396NCI NIH HHS P30 CA008748NCI NIH HHS P30-CA008748NCI NIH HHS R25 CA096945NIBIB NIH HHS NIH R01 EB017748NIBIB NIH HHS R01 EB017748NIDA NIH HHS K08 DA016396NIGMS NIH HHS T32 GM007739NINDS NIH HHS F31 NS076028
6 · The paper itself

Abstract

The current difficulty in visualizing the true extent of malignant brain tumors during surgical resection represents one of the major reasons for the poor prognosis of brain tumor patients. Here, we evaluated the ability of a hand-held Raman scanner, guided by surface-enhanced Raman scattering (SERS) nanoparticles, to identify the microscopic tumor extent in a genetically engineered RCAS/tv-a glioblastoma mouse model. In a simulated intraoperative scenario, we tested both a static Raman imaging device and a mobile, hand-held Raman scanner. We show that SERS image-guided resection is more accurate than resection using white light visualization alone. Both methods complemented each other, and correlation with histology showed that SERS nanoparticles accurately outlined the extent of the tumors. Importantly, the hand-held Raman probe not only allowed near real-time scanning, but also detected additional microscopic foci of cancer in the resection bed that were not seen on static SERS images and would otherwise have been missed. This technology has a strong potential for clinical translation because it uses inert gold-silica SERS nanoparticles and a hand-held Raman scanner that can guide brain tumor resection in the operating room.

Indexed as

NanoparticlesAnimalsBrain NeoplasmsGlioblastomaMiceSpectrum Analysis, Ramanbrain tumorsGBMglioblastoma multiformehand-held Raman scannerSERS-guided tumor resectionSERS nanoparticlessurface-enhanced Raman scattering (SERS)

Identifiers

PMID25093240
PMCPMC4212801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.